Hodgkin Lymphoma Clinical Trials in Minneapolis, Minnesota

3 studies are recruiting for hodgkin lymphoma in Minneapolis, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma

    This is a Phase I/II, multicenter, open-label, dose escalation/dose-expansion study to evaluate the tolerability, safety, and the maximum tolerated dose (MTD) of ruxolitinib when given with fixed dose nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma (cHL).

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Minnesota, Minneapolis, Minnesota
    Locations
    6 in total
    Run by
    Veronika Bachanova

    See if you can join NCT03681561 on ClinicalTrials.gov

  2. Auto Stem Cell Transplant for Lymphoma Patients

    This is a phase II study of autologous transplant for patients with Hodgkin (HL) and non-Hodgkin lymphomas (NHL) including those who are HIV positive.

    Stage
    Phase 2
    Ages
    Up to 75
    Site
    Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota
    Run by
    Masonic Cancer Center, University of Minnesota

    See if you can join NCT03125642 on ClinicalTrials.gov

  3. Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

    Tagraxofusp is a protein-drug conjugate consisting of a diphtheria toxin redirected to target CD123 has been approved for treatment in pediatric and adult patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). This trial aims to examine the safety of this novel agent in pediatric patie…

    Stage
    Phase 1
    Ages
    1 to 21
    Site
    Children's Hospital and Clinics of Minnesota, Minneapolis, Minnesota
    Locations
    31 in total
    Run by
    Therapeutic Advances in Childhood Leukemia Consortium

    See if you can join NCT05476770 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.